Ubs Asset Management Americas Inc Bio Rad Laboratories, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 388,627 shares of BIO stock, worth $93.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
388,627
Previous 441,098
11.9%
Holding current value
$93.3 Million
Previous $148 Million
13.49%
% of portfolio
0.03%
Previous 0.04%
Shares
29 transactions
Others Institutions Holding BIO
# of Institutions
458Shares Held
18.5MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$461 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$372 Million0.01% of portfolio
-
Veritas Asset Management LLP977KShares$235 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$179 Million0.06% of portfolio
-
Van Eck Associates Corp723KShares$174 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.92B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...